Asthma is a chronic disease that affects your airways. Your airways are tubes that carry air in and out of your lungs. If you have asthma, the inside walls of your airways become sore and swollen. That makes them very sensitive, and they may react strongly to things that you are allergic to or find irritating. When your airways react, they get narrower and your lungs get less air.
Do you experience poorly controlled asthma?
This clinical research study is looking at the safety and effectiveness of an investigational treatment option for people who have uncontrolled asthma.
Would you like to take part?
As a volunteer in a research study, you will receive study related medical care from the study doctor. The results of this research will be used to find out if the experimental medication being studied will be of benefit to other Canadians with asthma or not. Study volunteers are an important part of moving medical care forward.
You may qualify to participate in this study if you:
- Are male or female over the age of 18 years, or between the ages of 4 and 17 supported by a parent or guardian
- Have been diagnosed with asthma for at least 1 year prior to your screening visit
- Have been receiving 1 of the following scheduled asthma maintenance therapies for 3 months with stable dosing for at least the last 4 weeks before Visit 1:
- Medium to high dose ICS
- Medium to high dose ICS and 1 additional maintenance therapy from the following: LTRA, LAMA, or theophylline
- Low to high dose ICS in combination with LABA with or without one additional maintenance therapy from the following: LTRA, LAMA, or theophylline
- Have a documented history of at least 1 severe asthma exacerbation within 12 months before Visit 1
You may not qualify to participate if you:
- Are a pregnant female, or plan to become pregnant during the duration of the study
- Have COPD or other significant lung diseases
- Have used an oral or SCS within 6 weeks of Visit 1
- Currently smoke or have quit smoking less than 6 months before Visit 1
- Have a history or display current evidence of a clinically significant disease that could put your safety at risk
There are other eligibility requirements that the study doctor will review. Only the study doctor can finally determine whether you are eligible to participate in the study or not.